Home/Filings/4/0001209191-19-056633
4//SEC Filing

Shak Steven 4

Accession 0001209191-19-056633

CIK 0001131324other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 9:40 PM ET

Size

25.0 KB

Accession

0001209191-19-056633

Insider Transaction Report

Form 4
Period: 2019-11-08
Shak Steven
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-083,8570 total
    Exercise: $27.00Exp: 2026-02-16Common Stock (3,857 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0820,1800 total
    Exercise: $72.52Exp: 2029-01-29Common Stock (20,180 underlying)
  • Disposition to Issuer

    Common Stock

    2019-11-0849,5859,210 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2019-11-089,2100 total(indirect: By Trust)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0818,18623,384 total
    Exercise: $33.21Exp: 2028-01-31Common Stock (18,186 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0823,3840 total
    Exercise: $33.21Exp: 2028-01-31Common Stock (23,384 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0842,4233,857 total
    Exercise: $27.00Exp: 2026-02-16Common Stock (42,423 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0832,16814,622 total
    Exercise: $27.48Exp: 2027-01-31Common Stock (32,168 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0814,6220 total
    Exercise: $27.48Exp: 2027-01-31Common Stock (14,622 underlying)
Footnotes (9)
  • [F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $1,363,637 and 22,334 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F2]Disposed of in connection with the Merger, whereby Issuer restrict stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 7,047 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $695,344, less applicable tax withholdings, and 11,389 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F4]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 2,951 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
  • [F5]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $520,904, less applicable tax withholdings, and 8,532 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F6]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 11,190 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
  • [F7]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $251,614, less applicable tax withholdings, and 4,121 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F8]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 17,896 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
  • [F9]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 15,444 shares of Exact Sciences common stock with an exercise price of $94.76 per share.

Issuer

GENOMIC HEALTH INC

CIK 0001131324

Entity typeother

Related Parties

1
  • filerCIK 0001337334

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 9:40 PM ET
Size
25.0 KB